Twice daily application is well-tolerated
Het product is uitsluitend bedoeld voor onderzoeksdoeleinden en niet voor menselijk of veterinair gebruik
On-Therapy Monitoring Schedule Weeks 4 and 8: IGF-1, ALT, AST, albumin, fasting glucose, body weight Week 12: Full CMP, IGF-1, HbA1c, PT/INR, Child-Pugh re-score Every 3 months thereafter: IGF-1, liver panel, albumin Target IGF-1 in the mid-normal range for age and sex
R.SpitzerM.FaughtB.et al
Further analysis of signaling pathways confirmed that PD effectively upregulated endogenous TGF-/Nodal signaling and downstream Smad2/3 transduction, while concurrently downregulating BMP signaling, leading to robust DE formation